Our Core Team
Our diverse management group utilizes deep, early stage experience in the active guidance of the company. With a focus on aggressive market introduction and expertly handled economics, the collective blends the best of established practices with new innovations in business development.
Anthony Lando, CEO
Anthony is our co-founder and has served as Chief Executive Officer and Board member since the inception of SEBACIA in 2010. Anthony is also CEO of The Innovation Factory and previously served as Chief Operating Officer of BTG plc, a UK public-listed specialty pharmaceutical company.
Anthony's extensive experience includes operations, product development, intellectual property management, financial management, and fundraising for both public and private companies, as well as development and creation of technology-based entities.
Prior positions include leadership roles in marketing, sales, and engineering with Philips Medical Systems and Stone & Webster Engineering. Anthony has managed successful investments in and served on the boards of AqueSys Inc., Wave Tec Vision®, Halscion Inc (keloid scar treatment), and Primaxis Technology Ventures, Inc.
He lives in Suwanee, Georgia with his wife, daughter and Elvis...their black labradoodle.
Todd Meyer, COO and General Counsel
Prior to his role as COO and General Counsel of SEBACIA, Todd spent three years as the program manager for Halscion, Inc. while it was a portfolio company at The Innovation Factory. He also served as an associate within Gunderson Dettmer’s corporate transactions and intellectual property group and held pharmaceutical sales and marketing positions with both Astra USA and Abbott Laboratories.
Todd has been representing and working with life science technologies for more than 18 years. Currently, he is a member of the American Academy of Dermatology (AAD), Southeastern Medical Device Association (SEMDA), and the Association of University Technology Managers (AUTM); he is also a non-active member of the Massachusetts Bar.
When he's not coaching one of his two boys' lacrosse teams, Todd can be found sharpening his knife skills in the kitchen or twirling his Terrible Towel™ during Pittsburgh Steelers games.
Dilip Paithankar, PhD, CTO
Dilip has served as Chief Technology Officer for SEBACIA since the founding of the company. Prior to this role, he served as the VP of Research and Development at Cellutions, a start-up company within the Innovation Factory. This position was preceded by research and product development roles at Candela Corporation, a leading laser dermatology company and a focus on laser-based diagnostic methods at Wellman Center for Photomedicine (MGH) and Purdue University.
A fellow of the American Society of Lasers in Surgery and Medicine, Dilip has been working with medical device technology and development for more than 17 years.
In his spare time, Dilip can be found coaching his kids' soccer teams and working on his Table Tennis loop shot.
Robert Leslie, CFO
Bob has served as CFO of SEBACIA since the company's inception. He is presently the Vice President of Finance and Administration at The Innovation Factory (TIF), assuming the role of CFO-in-residence of current and former TIF portfolio companies, including Halscion, Inc., Novalign, Inc., AqueSys, Inc., and Cellutions, Inc.
Before joining SEBACIA, he held senior financial management positions with several venture capital (VC)-financed technology and manufacturing companies. He also served as Chief Financial Officer of Cordova Ventures, a VC firm located in Atlanta, Georgia. Bob maintains a Certified Public Accountant’s license in the state of Texas.
An avid long distance runner, Bob has completed six full marathons and 20+ half marathons. He also enjoys physical fitness and watching Major League Baseball.
Cory Anderson, VP, Clinical Marketing
Cory is responsible for international post approval studies and commercial launch activities for the Sebacia Acne Treatment. Since starting with The Innovation Factory (TIF) over 10 years ago, he has worked in a variety of roles in TIF and TIF’s portfolio companies. These positions include his current role with Sebacia, VP of Business Development for TIF, and Program Manager for both AqueSys and NeoVista. Additionally, Cory is a Principal at Accuitive Medical Ventures. He currently serves as an observer on the MyoScience board and formally served as an observer on the Aquesys board (Acquired by Allergan).
Cory earned his MBA from Emory University and both his Bachelor and Master degrees in Biomedical Engineering from Tulane University.
In his spare time, Cory enjoys spending time with his two young children and experimenting with different dishes in the kitchen.
Gretchen Richards, VP, Clinical & Regulatory Affairs
Gretchen recently joined Sebacia to lead clinical development and regulatory affairs. After earning a Master’s Degree in Molecular Biology, she spent a short time as a research scientist in academia before making the transition to the biopharmaceutical industry. Over the past 25 years, Gretchen has advanced numerous medical products through early stage development to proof of concept and pivotal trials. She played an integral role in leading late stage clinical trials of Velcade® (Takeda Millennium Pharmaceuticals) and Kalbitor® (Dyax Corporation).
Prior to joining Sebacia, Gretchen led clinical research and program teams at several biopharmaceutical startup organizations including Molecular Insight Pharmaceuticals, Nucryst Pharmaceuticals, MacroChem Corporation and Hybridon, Inc. She has also held clinical operations positions at two contract research organizations. As a result, Gretchen’s development experience spans a wide variety of therapeutic areas and includes investigational drugs, biologics and medical devices.
Gretchen lives with her husband and their Jack Russell Terrier, Oliver. She enjoys swimming, hiking, kayaking, playing ball with Oliver and most things that allow her to enjoy the outdoors.
Richard Blomgren, Director Quality
Richard has been the guiding force for Sebacia Quality and Manufacturing, as part of The Innovation Factory (TIF) management team. In his role as Director of Quality Systems for TIF for the past 12 years, Richard brings more than 20 years expertise in quality, manufacturing, and product development. During his time at TIF, Richard has created and managed quality systems for 10 medical startup companies and helped to successfully transition 7 of these companies out of TIF.
Prior to joining TIF, Richard held quality management and quality engineering positions at Teleflex Medical (formerly Rüsch), MMG Healthcare, GEC Marconi Avionics, and Rockwell International.
Away from work, Richard enjoys hiking and camping with his four sons and volunteers as an Assistant Scoutmaster for their local Boy Scout troop.
Pedro Medrano, VP, Engineering & Program Management
Pedro recently joined Sebacia to lead engineering and commercialization readiness projects. After earning a B.S. Degree in Materials Science & Engineering, he spent time researching high energy density capacitors for use in numerous applications, including Implantable Defibrillators. During his 15 years at St. Jude Medical, Inc., Pedro led numerous global, cross-functional teams in the development of Class III implantable devices and systems.
Prior to joining Sebacia, Pedro was the Director of the Project Management Office for Philips’ Nuclear Medicine/Imaging business, responsible for New Product Development and Sustaining programs. He has also held Business Development positions with Novartis’ Eyecare Division (CIBAVISION/Alcon) and The Innovation Factory where he performed due diligence on refractive laser surgery, Intraocular and Contact Lenses, and drug delivery devices.
In his spare time, Pedro enjoys participating in and watching all types of sports with his 3 boys.